SFMG Wealth Advisors’s VanEck Pharmaceutical ETF PPH Stock Holding History

SFMG Wealth Advisors’s Portfolio PPH Stock Details PPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-3,000	Closed	-$212K	–	127
2015 Q2	$212K	Sell	3,000 -3,000	-50%	-$216K	0.05%	108
2015 Q1	$421K	Buy	+6,000	New	+$407K	0.03%	113

Other funds holding PPH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

MIM

Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return

AHS

Aspiriant Holdings S3 Los Angeles, California $233M AUM 3.13% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

SFMG Wealth Advisors's PPH Position: Q3 2015 in Review

SFMG Wealth Advisors sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2015, closing a stake of 3,000 shares — an estimated $212K sold.

SFMG Wealth Advisors first reported a position in PPH in Q1 2015 and held it in 2 quarters. The position peaked at $421K in Q1 2015. 60 funds tracked by Wall St. Rank hold PPH as of Q3 2015.

SFMG Wealth Advisors reported no remaining VanEck Pharmaceutical ETF position as of Q3 2015 after selling out during the quarter.
SFMG Wealth Advisors sold 3,000 VanEck Pharmaceutical ETF shares in Q3 2015, an estimated $212K.
SFMG Wealth Advisors first reported a position in VanEck Pharmaceutical ETF in Q1 2015 and held it in 2 quarters.
SFMG Wealth Advisors's VanEck Pharmaceutical ETF position peaked at $421K in Q1 2015.
60 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2015.

Based on SFMG Wealth Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.